2-vanillin has been researched along with Intervertebral Disc Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherif, H; Haglund, L; Jarzem, P; Li, L; Mannarino, M; Navarro-Ramirez, R; Ouellet, JA; Sheng, K; Wu-Martinez, O | 1 |
| Bisson, DG; Cherif, H; Haglund, L; Mannarino, M; Ouellet, JA; Rabau, O | 1 |
| Cherif, H; Haglund, L; Jarzem, P; Li, L; Mannarino, M; Ouellet, JA; Rabau, O; Sheng, K; Weber, MH | 1 |
3 other study(ies) available for 2-vanillin and Intervertebral Disc Degeneration
| Article | Year |
|---|---|
Senolytic Combination Treatment Is More Potent Than Single Drugs in Reducing Inflammatory and Senescence Burden in Cells from Painful Degenerating IVDs.
Topics: Adjuvants, Immunologic; Animals; Benzaldehydes; Humans; Intervertebral Disc Degeneration; Low Back Pain; Rats; Senotherapeutics | 2023 |
Senotherapeutic drugs for human intervertebral disc degeneration and low back pain.
Topics: Benzaldehydes; Cellular Senescence; Female; Humans; Imidazolines; Intervertebral Disc Degeneration; Low Back Pain; Male | 2020 |
Toll-like receptor 2 induced senescence in intervertebral disc cells of patients with back pain can be attenuated by o-vanillin.
Topics: Benzaldehydes; Cellular Senescence; Humans; Intervertebral Disc; Intervertebral Disc Degeneration; Low Back Pain; Toll-Like Receptor 2 | 2021 |